Effect of Qualifying Atherosclerotic Cardiovascular Disease Diagnosis Proximity on Cardiovascular Risk and Benefit of Empagliflozin in the EMPA-REG OUTCOME Trial

Effect of Qualifying Atherosclerotic Cardiovascular Disease Diagnosis Proximity on Cardiovascular Risk and Benefit of Empagliflozin in the EMPA-REG OUTCOME Trial

Background: In patients with type 2 diabetes mellitus (T2DM), a history of an ischemic event is associated with increased risk for cardiovascular (CV) disease. Whether patients with T2DM and a recent atherothrombotic diagnosis benefit from early intervention with a sodium-glucose co-transporter 2 in...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Ayodele Odutayo, MD, DPhil, Bernard Zinman, MD, Christoph Wanner, MD, Isabella Zwiener, PhD, Søren S. Lund, MD, Stefan Hantel, PhD, David Fitchett, MD, Jacob A. Udell, MD
Formaat: Artikel
Taal:English
Gepubliceerd in: Elsevier 2024-07-01
Reeks:CJC Open
Online toegang:http://www.sciencedirect.com/science/article/pii/S2589790X24000490

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X24000490

Gelijkaardige items